Objective: The purpose of this study was to describe the relationship between intra-and extracranial anomalies and neurodevelopmental outcome for fetuses diagnosed with a posterior fossa anomaly (PFA) on fetal MRI. Results: PFAs were identified in 59 fetuses; 9 with DWM, 36 with VH, and 14 with MCM.
. Neurodevelopmental outcome for 10 cases with mega cisterna magna.
Introduction
Posterior fossa anomalies (PFAs), including Dandy-Walker malformation (DWM), vermian hypogenesis/hypoplasia (VH), and mega cisterna magna (MCM), are found in approximately 1 in every 5,000 live births (Bolduc and Limperopoulos, 2009 ). The identification of a PFA leads to a thorough ultrasound exam or fetal MRI when available. Fetal MRI provides detailed imaging of the soft tissue of the brain to help differentiate between DWM, VH, and MCM, which have different prognoses du Plessis, 2006, Adamsbaum et al., 2005) . Fetuses suspected of having a PFA are at an increased risk for both additional intra-and extra-cranial anomalies. Several studies have reported the importance of the identification of additional anomalies for providing accurate prognoses to families (Cornford and Twining, 1992 , Estroff et al., 1992 , Ecker et al., 2000 .
Neurologic complications and developmental delay are commonly seen in children with
PFAs. Many studies have reported the rate of developmental delay in children identified with a PFA ranging from 20-80% depending on the specific anomaly and case series , Bolduc and Limperopoulos, 2009 , Gerszten and Albright, 1995 , Ecker et al., 2000 . The lack of evidence-based outcome data for fetuses diagnosed with PFAs makes it difficult to provide prognostic information to families receiving a prenatal diagnosis.
The purpose of this study was to describe the relationship between intra-and extracranial anomalies and neurodevelopmental outcome for fetuses diagnosed with a posterior fossa anomaly (PFA) on fetal MRI consecutively between January 2004 and December 2010 from a single quaternary care center.
.
Methods
After receiving Institutional Review Board approval, a retrospective chart review was conducted at the Fetal Care Center of Cincinnati (FCC) at Cincinnati Children's Medical Center.
All fetal MRIs were reviewed by a radiologist to assess accuracy of diagnosis and identify additional defects. Postnatal images were reviewed when available. Diagnosis of Dandy-Walker malformation was made in the presence of vermian agenesis/hypogenesis, cystic dilatation of the fourth ventricle and enlarged posterior fossa with elevation of the transverse sinus, tentorium and torcula ( Figure 1 ). Vermian abnormalities were described based on standardized measurements described by Garel (2009) and Robinson et al (2001) . Vermian hypogenesis was noted if the vermis measured small and the fastigial to declive line was less than a 1:2 ratio. The diagnosis of vermian hypoplasia was verified in the presence of a small vermis with normal foliation (Figure 2 ). Due to the sample size, vermian hypogenesis and hypoplasia were treated as one group for the purpose of analysis. The brainstem was identified as abnormal if small or irregular in configuration compared to normal brainstem measurement standards for gestational age described by Tilea et al (2009) (Figure 4 ).
Data was collected from medical records (prenatal and postnatal) (Appendix 1) with additional information collected through a voluntary parental phone interview (Appendix 2).
Women who were referred to FCC for evaluation but experienced a prenatal or perinatal demise
were not contacted for the phone interview but were included in the chart review. Data collected from medical record review and phone surveys included the outcome of the pregnancy (delivery, stillbirth, intrauterine fetal demise or termination), medical history of the pregnancy, postnatal Of the 9 cases with DWM, 2 were electively terminated and 1 died neonatally. All 6 survivors had developmental and neurologic abnormalities ( Table 2 ). The mean age at the time of the study was 2.3 years old (range: 2 months to 4.5 years). DWM was isolated in 1 case, occurred with only additional extra-cranial anomalies in 1 case, and occurred with both intraand extra-cranial anomalies in 7 cases.
Vermian abnormalities were identified in 36 cases. Vermian hypogenesis was seen in 4 individuals (cases 5, 15, 18 and 27) , while the remaining 32 cases were diagnosed with vermian hypoplasia. Neonatal death occurred in 10 cases, 1 was electively terminated, and 2 were lost to follow up. Additionally, 2 individuals died during the first year of life, leaving 21 cases with postnatal information available (Table 3) . Of the 21 living cases, neurodevelopmental outcome varied greatly ( Figure 5 ). Five cases had both additional intra-and extra-cranial anomalies; all had abnormal neurodevelopmental outcome.
Mega cisterna magna was identified in 14 cases. Neurodevelopmental outcome information was available for 10 cases (Table 4 ) and 4 cases were lost to follow up. The MCM was isolated in 7 cases, all of which had normal neurologic and developmental outcomes. Extracranial anomalies were identified in 3 cases with MCM; all 3 had neurologic abnormalities and 2 out of 3 also had developmental delay.
The strength of association between PFAs and neurodevelopmental outcome was examined for 50 of the 59 cases under the following conditions: isolated or when seen in the presence of intra-cranial abnormalities, extra-cranial abnormalities, or an abnormal brainstem.
Those lost to follow up (6/59) or terminated (3/59) were excluded. The average age at the time neurodevelopmental outcome was gathered was 2.9 years old (range: 1 month to 6.5 years).
Cases with isolated PFAs had statistically better neurodevelopmental outcomes than cases identified with additional anomalies (14/50 and 36/50, respectively; p=0.00016). Cases with additional intra-cranial anomalies were more likely to have a poor outcome compared to those without additional intra-cranial anomalies (26/50 and 24/50 respectively; p=0.00085). Similarly, the presence of extra-cranial anomalies was associated with a worse outcome compared to those without extra-cranial anomalies (30/50 and 20/50 respectively; p=0.00014). The presence of extra-cranial anomalies with a PFA increased the likelihood of having a poor neurodevelopmental outcome or death (OR=10.2, 95% CI, 2.6-40). Brainstem abnormalities were identified in 15 cases (30%); of these, 9 died and 6 have neurologic abnormalities and severe developmental delay. The presence of a brainstem abnormality was related to a significantly worse outcome compared to those with normal brainstems (15/50 and 35/50 respectively; p=0.00018) and increased the odds of having a poor neurodevelopmental outcome or death (OR=12.97, 95% CI, 2.9-58.0).
Discussion
Posterior fossa anomalies are a relatively common finding on prenatal ultrasound. The variation in neurodevelopmental outcome seen between different PFAs as well as within each specific anomaly is great, making counseling families receiving this diagnosis challenging.
Many studies have reported a relationship between additional intra-and extra-cranial anomalies and neurodevelopmental outcome (Kolble et al., 2000 , Ecker et al., 2000 , Forzano et al., 2007 , Bolduc and Limperopoulos, 2009 . In this study, the identification of additional intra-cranial anomalies or extra-cranial anomalies was associated with a worse outcome regardless of the type of PFA. These results support previous studies in emphasizing the importance of a full anatomic scan to establish whether additional intra-or extra-cranial anomalies are present (Levine et al., 1999 , Adamsbaum et al., 2005 . Additionally, fetal MRI provides detailed information about neuroanatomy and can identify brain anomalies, such as heterotopia or abnormal gyria that could be missed on a level II ultrasound. Considering 20% of cases of DWM, VH, and non-isolated MCM had a chromosome abnormality detected, an amniocentesis with chromosome analysis and high density microarray should be considered in the diagnostic work-up for a fetus identified with a PFA.
Of children who had a poor outcome, the odds that they had a brainstem abnormality were greater than the odds that they had an extra-cranial abnormality. To the knowledge of the authors, a statistical analysis of the relationship between brainstem abnormalities and outcome for individuals with a PFA has not been previously reported in the literature. Although previous studies have not treated brainstem abnormalities as a separate risk factor from other anomalies, our analysis demonstrates that when abnormal, the brainstem is important for predicting neurodevelopmental outcome. All brainstem abnormalities in this study led to a poor outcome, with a significant number of neonatal deaths. The literature on specific syndromes involving brainstem abnormalities, such as Walker Warburg syndrome, indicates that the outcome is poor when the brainstem is involved (Vajsar and Schachter, 2006) . It therefore is important that families should be given a guarded prognosis when a brainstem abnormality is found in addition to a PFA, regardless of whether additional anomalies or a specific syndrome is identified.
In previous literature, neurodevelopmental delay occurs in 40-60% of children with DWM, with the identification of additional anomalies leading to a worse prognosis . In this study all but one case had additional intra-and/or extracranial anomalies and all living children had hydrocephalus which required a shunt. These findings suggest that a DWM is more likely to be found in the presence of additional anomalies rather than as an isolated occurrence. Similar to previous studies where high rates of additional anomalies were found (Long et al., 2006) , all cases of DWM in this study had a poor outcome.
Unlike DWM, classification of vermian abnormalities has changed rapidly in the last ten years leading to difficulties in making meaningful comparison between studies looking at vermian hypoplasia, Dandy-Walker variant, Dandy-Walker continuum, and Dandy-Walker complex. Although there were not enough cases in our study population to perform statistical analysis, there did not appear to be a difference in outcome between cases with vermian hypogenesis versus vermian hypoplasia. Postnatal confirmation of VH was made in 83% of cases, demonstrating that false positive diagnoses can still occur when the fetal MRI is performed before 24 weeks. This is similar to previously reported confirmation rates, and is thought to be due to normal variation in development . Many studies have reported a better prognosis for individuals with isolated VH compared to individuals with VH and additional anomalies (Bolduc and Limperopoulos, 2009, Harper, 2007) ; however, isolated VH did not have a better prognosis in this study. Despite the insignificance of VH with intra-or extra-cranial anomalies separately, when both were present the outcome was universally poor, with all having either poor neurodevelopmental outcome or death. These findings are similar to a previous report that risk for death increases significantly when additional anomalies are found in two or more organ systems (Salihu et al., 2008) .
The question of whether an isolated MCM (≥10 mm) is pathogenic or a benign variant in human development has important implications for parents who are be considering termination.
This study adds to the current literature which is consistent with a normal neurodevelopmental postnatal outcome for fetuses with an isolated MCM (Bolduc and Limperopoulos, 2009 , Adamsbaum et al., 2005 , Long et al., 2006 , Haimovici et al., 1997 , Dror et al., 2009 , Forzano et al., 2007 . Previous reports indicate that non-isolated cases of MCM have good outcomes in 11-29% of cases (Forzano et al., 2007 , Long et al., 2006 . The non-isolated cases of MCM in this study had a worse outcome than has been reported in the literature, with all having neurologic abnormalities and/or developmental delay. However, this group only included three cases and therefore may not represent the true variation in neurodevelopmental outcome that exists in the larger population.
An important limitation of this study was the lack of standardized evaluation of neurodevelopmental outcome. In a review of studies looking at neurodevelopmental outcome in children with cerebellar malformations, 74% of studies shared this same limitation (Bolduc and Limperopoulos, 2009) . Although both parental report and medical records review were utilized to assess neurodevelopmental outcome, it is possible that subtle deficits that have been reported in adult studies could have been missed (Zimmer et al., 2007) .
Conclusion
This study includes a large series of fetuses identified with PFAs on fetal MRI. The availability of pediatric follow up information has made it possible to identify several features that correspond with prognosis and may be useful when counseling families receiving this diagnosis. Additional intra-and extra-cranial anomalies are indicative of a worse outcome than isolated PFAs. In the absence of a brainstem abnormality or both intra-and extra-cranial anomalies, the prognosis for VH varies from normal to poor, making counseling families for VH difficult. Additionally, fetal MRI to assess VH before 24 weeks is associated with an increased likelihood of having a false positive result. This may limit the utility for families who are considering termination, as there are gestational age restrictions for termination in most states.
Since having a brainstem abnormality increased the likelihood of having a poor outcome 13-fold, the importance of examining the brainstem to help establish risk for poor outcome should be emphasized. Isolated MCM had a good prognosis, and is likely a normal variant, while the outcome for non-isolated cases of MCM is more guarded. This means that the identification of MCM on ultrasound should prompt providers to evaluate the fetus for additional anomalies in order to provide accurate counseling to families. Although this study is limited because of its retrospective nature, it emphasizes the utility of fetal MRI to characterize the brain and identify additional anomalies when a PFA is suspected. Prospective studies using standardized outcome measures in a number of functional domains will be important for identifying specific areas of deficit for individuals diagnosed with a PFA. 
